AOP Health is a European pioneer in developing integrated therapies for rare diseases and in critical care. Over the past 25 years, the company has expanded its reach with subsidiaries and representative offices throughout Europe and the Middle East. From the headquarters in Vienna AOP Health covers the full product lifecycle: nonclinical, clinical, pharmaceutical research and development, regulatory, medical, pharmacovigilance, quality and supply chain, market access, and distribution.
R&D:AOP Health focuses on rare diseases in hemato-oncology, cardiology & pulmonology, neurology and on critical care. AOP is striving to bring innovative therapies to patients with unmet medical needs. Their research heavily emphasizes the development of treatments for rare, complex, and life-threatening conditions through partnerships with academic institutions and biotechnology firms.
Production:AOP Health operates a fully integrated pharmaceutical business model, covering the entire life cycle of drug development, from early research to manufacturing. AOP Health works with many CMOs in Europe for a robust supply chain that can serve patients globally.
Services:Within the AOP Health Group: AOP Orphan Pharmaceuticals GmbH investigates, researches, develops, and provides therapies (i.e. medicinal products) worldwide. OrphaCare provides medical devices for PAH patients and related technical information and support for patients and experts. SciPharm is developing and distributing medical devices, i.e. infusion pumps.
Sales/Distribution:AOP Health operates across Europe and the Middle East through a network of subsidiaries and representative offices. Outside this territory distribution partners contribute to sales in 55 countries worldwide. AOP Health has a strong presence in delivering therapeutic solutions to niche markets, often being the sole supplier of critical medications for very specific, rare diseases worldwide.
Leopold-Ungar-Platz 2
Wien
Contact:
Telephone: 436763034399
Email: johanna.grames@aop-health.com
Website